Status | Study |
Recruiting |
Study Name: Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly Condition: Acromegaly Date: 2016-01-28 Interventions: Drug: Octreotide capsules Octr |
Not yet recruiting |
Study Name: Dynamic Hormone Diagnostics in Endocrine Disease Condition: Adrenal Insufficiency Congenital Adrenal Hyperplasia Cushi Date: 2016-01-12 Interventions: Other: 27 hour subcutaneous fluid sampling One hour prior |
Recruiting |
Study Name: Cardiac (CMRI) Assessment of Acromegaly Condition: Acromegaly Date: 2015-12-08 Interventions: Device: CMRI Myocardial Imagin |
Active, not recruiting |
Study Name: Pasireotide LAR and Pegvisomant Study in Acromegaly Condition: Acromegaly Date: 2015-12-07 Interventions: Drug: Pasireotide LAR 60 mg as |
Not yet recruiting |
Study Name: Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly Cardiomyopathy Condition: Acromegaly Cardiomyopathy Date: 2015-11-18 Interventions: Drug: Tadalafil Tadalafil 20 mg to be taken orally once daily, for 5 months |
Active, not recruiting |
Study Name: Validation Study of the SAGIT® Instrument in Acromegaly Condition: Acromegaly Date: 2015-07-07 |
Completed |
Study Name: Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly Condition: Acromegaly Date: 2015-07-07 Interventions: Drug: Lanreotide Autogel® |
Recruiting |
Study Name: Assessment of Airway in Patients With Acromegaly for Predicting Successful Tracheal Intubation Condition: Acromegaly Date: 2015-03-23 Interventions: Device: Fiberoptic In the event of failed intubation under direct laryngoscopy, fiberoptic intubation wi |
Active, not recruiting |
Study Name: Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment. Condition: Acromegaly Date: 2015-03-18 |
Recruiting |
Study Name: Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly Condition: Acromegaly Date: 2015-03-18 Interventions: Drug: Lanreotide PRF Other Name: Lanreotide acetate |